Shyam Aggarwal

Carfilzomib–dexamethasone vs bortezomib–dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR

W-J Chng, Hartmut Goldschmidt, Meletios Α. Dimopoulos et al. · Leukemia · 2016 · 58 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing–based cohort study

Mayank Jauhri, Akanksha Bhatnagar, Satish Gupta et al. · Tumor Biology · 2017 · 54 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from India

Ramesh Nimmagadda, Raghunadharao Digumarti, Reena Nair et al. · Indian Journal of Medical and Paediatric Oncology · 2013 · 38 citations · Full text

Medicine, Hematology, Pathology +15

INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids

Anil Arora, Anil C. Anand, Ashish Kumar et al. · Journal of Clinical and Experimental Hepatology · 2018 · 34 citations · Full text

Pharmacy, Infectious Diseases, Oncology +14

Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing

Mayank Jauhri, Akanksha Bhatnagar, Satish Gupta et al. · Medical Oncology · 2016 · 32 citations

Medicine, Genetics, Molecular Genetics +17